Royal Bank of Canada’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-94,260
Closed -$2.23M 7158
2023
Q4
$2.23M Buy
94,260
+22,811
+32% +$539K ﹤0.01% 2557
2023
Q3
$1.07M Buy
71,449
+65,361
+1,074% +$974K ﹤0.01% 2951
2023
Q2
$67K Buy
6,088
+6,062
+23,315% +$66.7K ﹤0.01% 5178
2023
Q1
$0 Sell
26
-10,553
-100% ﹤0.01% 7065
2022
Q4
$66K Buy
10,579
+2,998
+40% +$18.7K ﹤0.01% 5269
2022
Q3
$27K Buy
7,581
+6,331
+506% +$22.5K ﹤0.01% 5542
2022
Q2
$4K Sell
1,250
-3,979
-76% -$12.7K ﹤0.01% 6309
2022
Q1
$16K Sell
5,229
-8,482
-62% -$26K ﹤0.01% 6249
2021
Q4
$46K Buy
13,711
+5,105
+59% +$17.1K ﹤0.01% 5888
2021
Q3
$31K Buy
8,606
+2,456
+40% +$8.85K ﹤0.01% 5931
2021
Q2
$27K Sell
6,150
-1,128
-15% -$4.95K ﹤0.01% 5904
2021
Q1
$33K Buy
7,278
+5,698
+361% +$25.8K ﹤0.01% 5645
2020
Q4
$9K Buy
1,580
+309
+24% +$1.76K ﹤0.01% 5895
2020
Q3
$9K Sell
1,271
-1,042
-45% -$7.38K ﹤0.01% 5480
2020
Q2
$8K Sell
2,313
-11,659
-83% -$40.3K ﹤0.01% 5446
2020
Q1
$20K Buy
+13,972
New +$20K ﹤0.01% 5061
2019
Q4
Sell
-131
Closed -$1K 6409
2019
Q3
$1K Sell
131
-21
-14% -$160 ﹤0.01% 5862
2019
Q2
$1K Sell
152
-50
-25% -$329 ﹤0.01% 5780
2019
Q1
$2K Buy
202
+108
+115% +$1.07K ﹤0.01% 5542
2018
Q4
$1K Sell
94
-1,013
-92% -$10.8K ﹤0.01% 5707
2018
Q3
$12K Buy
+1,107
New +$12K ﹤0.01% 5306
2018
Q2
Sell
-1,200
Closed -$16K 6128
2018
Q1
$16K Buy
+1,200
New +$16K ﹤0.01% 4936
2017
Q4
Sell
-5
Closed 6114
2017
Q3
$0 Buy
+5
New ﹤0.01% 6179